Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
COYA-301 by Coya Therapeutics for Alzheimer's Disease: Likelihood of Approval
COYA-301 is under clinical development by Coya Therapeutics and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
COYA-301 by Coya Therapeutics for Alzheimer's Disease: Likelihood of Approval
COYA-301 is under clinical development by Coya Therapeutics and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...